Mónica Sancho

7PUBLICATIONS
11CO-AUTHORS
Molecular targetsPredictive and prognostic markersAutoimmunityCharacterisation of biological macromoleculesHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 03, 2026
Disruption of MCL1/BOK transmembrane interaction as a novel strategy to induce cell death in tumours.

|Apr 26, 2024
Phenotyping of cancer-associated somatic mutations in the BCL2 transmembrane domain.

Diego Leiva, Estefanía Lucendo, Alicia Belén García-Jareño

|Feb 15, 2022
Identification of NLRP3PYD Homo-Oligomerization Inhibitors with Anti-Inflammatory Activity.

Soroush Moasses Ghafary, Paula M Soriano-Teruel, Shima Lotfollahzadeh

|Dec 14, 2021
Identification of an ASC oligomerization inhibitor for the treatment of inflammatory diseases.

Paula M Soriano-Teruel, Guillermo García-Laínez, María Marco-Salvador

|Jul 26, 2021
Understanding MCL1: from cellular function and regulation to pharmacological inhibition.

Mónica Sancho, Diego Leiva, Estefanía Lucendo

|Feb 08, 2021
BOK-MCL1 transmembrane interactions: a challenging target for cancer therapy.

Mónica Sancho, Mar Orzáez

Pageof 2

Frequent Collaborators

5 joint publications

Mar Orzáez

2 joint publications

Waldemar Kulig

1 joint publications

F Lucantoni

1 joint publications

A J Garcia-Saez